Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome

Conditions:   Psoriasis;   Metabolic Syndrome Interventions:   Drug: Secukinumab;   Drug: Methotrexate Sponsor:   Universita di Verona Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials